Health In Tech Affirms FY2026 Sales Guidance of $45.000M-$50.000M vs $46.528M Est

Benzinga Newsdesk www.benzinga.com Negative 66.6%

Neg 66.6% Neu 0% Pos 0%

Health In Tech (NASDAQ:HIT) affirms FY2026 sales outlook from $45.000 million-$50.000 million to $45.000 million-$50.000 million vs $46.528 million estimate.